Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 1/20 | 0.61 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.61 |
| ▸ | CDK2 | P24941 | 1/20 | 0.61 |
| ▸ | CCND3 | P30281 | 1/20 | 0.61 |
| ▸ | CDK9 | P50750 | 1/20 | 0.61 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.61 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.60 |
| ▸ | INSR | P06213 | 1/20 | 0.60 |
| ▸ | IGF1R | P08069 | 1/20 | 0.60 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.60 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.60 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.59 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.59 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.59 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.59 |
| ▸ | EGFR | P00533 | 3/20 | 0.59 |
| ▸ | JAK2 | O60674 | 1/20 | 0.59 |
| ▸ | JAK1 | P23458 | 1/20 | 0.59 |
| ▸ | TTK | P33981 | 1/20 | 0.59 |
| ▸ | JAK3 | P52333 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3337236 | 0.91 | MAPK8 (0.66) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300728 | 0.91 | NTRK1 (0.71) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL3335625 | 0.86 | PKMYT1 (0.68) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300729 | 0.86 | PKMYT1 (0.60) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300731 | 0.85 | MAPK8 (0.64) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300727 | 0.84 | MAPK8 (0.62) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13320274 | 0.83 | STAT6 (0.59) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300743 | 0.82 | MAPK8 (0.71) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300661 | 0.81 | MAPK8 (0.70) | CCNKCCNA2CDK2CCND3CDK9 | |
| SCHEMBL13300733 | 0.81 | PKMYT1 (0.68) | CCNKCCNA2CDK2CCND3CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100144732-A1 | PYRIMIDINE KINASE INHIBITORS | GENENTECH, INC. | 2010-06-10 | — | — | US | disclosed |
| US-20100144732-A1 | PYRIMIDINE KINASE INHIBITORS | GENENTECH, INC. | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144732-A1 | PYRIMIDINE KINASE INHIBITORS | DTYMK, DCK, TYMP | CCNK 28/4885CCNA2 375/4885CDK2 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.